

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pyrimidine nucleobase catabolic process (GO:0006208) | 6.99064602 |
| 2 | synaptic vesicle exocytosis (GO:0016079) | 5.43110537 |
| 3 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.33210550 |
| 4 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 5.26740512 |
| 5 | nucleobase catabolic process (GO:0046113) | 5.25105717 |
| 6 | vocalization behavior (GO:0071625) | 5.16541285 |
| 7 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.85151115 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.79092002 |
| 9 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 4.78451958 |
| 10 | response to pheromone (GO:0019236) | 4.75192160 |
| 11 | glutamate receptor signaling pathway (GO:0007215) | 4.74791491 |
| 12 | protein localization to synapse (GO:0035418) | 4.72811380 |
| 13 | glutamate secretion (GO:0014047) | 4.71492682 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.66877179 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.61687061 |
| 16 | neuron cell-cell adhesion (GO:0007158) | 4.55051129 |
| 17 | cerebellar granule cell differentiation (GO:0021707) | 4.49421158 |
| 18 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.41694851 |
| 19 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.40165716 |
| 20 | positive regulation of synapse maturation (GO:0090129) | 4.39834966 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.33871201 |
| 22 | synaptic vesicle maturation (GO:0016188) | 4.26695815 |
| 23 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.23017609 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.20765568 |
| 25 | * neurotransmitter secretion (GO:0007269) | 4.20350973 |
| 26 | neuron-neuron synaptic transmission (GO:0007270) | 4.18952675 |
| 27 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.16779418 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.13292504 |
| 29 | cellular potassium ion homeostasis (GO:0030007) | 4.10034138 |
| 30 | neuronal action potential propagation (GO:0019227) | 4.07809874 |
| 31 | synaptic transmission, glutamatergic (GO:0035249) | 4.07396937 |
| 32 | synaptic vesicle endocytosis (GO:0048488) | 4.06075004 |
| 33 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.04453417 |
| 34 | central nervous system projection neuron axonogenesis (GO:0021952) | 4.02341017 |
| 35 | cell migration in hindbrain (GO:0021535) | 4.01932209 |
| 36 | regulation of synaptic vesicle transport (GO:1902803) | 3.97940258 |
| 37 | locomotory exploration behavior (GO:0035641) | 3.95278638 |
| 38 | sodium ion export (GO:0071436) | 3.79960895 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.75400109 |
| 40 | response to histamine (GO:0034776) | 3.72840196 |
| 41 | neuronal ion channel clustering (GO:0045161) | 3.67875129 |
| 42 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.67591565 |
| 43 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.67210138 |
| 44 | presynaptic membrane assembly (GO:0097105) | 3.64344166 |
| 45 | gamma-aminobutyric acid transport (GO:0015812) | 3.62393758 |
| 46 | behavioral response to cocaine (GO:0048148) | 3.61775518 |
| 47 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.61572436 |
| 48 | * neurotransmitter transport (GO:0006836) | 3.59941999 |
| 49 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.57072829 |
| 50 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.55990135 |
| 51 | detection of light stimulus involved in visual perception (GO:0050908) | 3.55990135 |
| 52 | regulation of synapse maturation (GO:0090128) | 3.54391227 |
| 53 | detection of molecule of bacterial origin (GO:0032490) | 3.53587936 |
| 54 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.53495685 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.53264926 |
| 56 | membrane depolarization during action potential (GO:0086010) | 3.52753830 |
| 57 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.51937283 |
| 58 | innervation (GO:0060384) | 3.45637648 |
| 59 | long-term synaptic potentiation (GO:0060291) | 3.44546296 |
| 60 | presynaptic membrane organization (GO:0097090) | 3.44509485 |
| 61 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.42482485 |
| 62 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.42053197 |
| 63 | regulation of neurotransmitter secretion (GO:0046928) | 3.37150797 |
| 64 | exploration behavior (GO:0035640) | 3.34870105 |
| 65 | postsynaptic membrane organization (GO:0001941) | 3.34417213 |
| 66 | membrane hyperpolarization (GO:0060081) | 3.33283825 |
| 67 | L-amino acid import (GO:0043092) | 3.32712919 |
| 68 | long-term memory (GO:0007616) | 3.31360254 |
| 69 | cell differentiation in hindbrain (GO:0021533) | 3.31193857 |
| 70 | synapse assembly (GO:0007416) | 3.30005956 |
| 71 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.29179277 |
| 72 | neuron recognition (GO:0008038) | 3.25054964 |
| 73 | prepulse inhibition (GO:0060134) | 3.23499002 |
| 74 | regulation of synapse structural plasticity (GO:0051823) | 3.21609409 |
| 75 | adult walking behavior (GO:0007628) | 3.20954703 |
| 76 | positive regulation of membrane potential (GO:0045838) | 3.20282151 |
| 77 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.20111636 |
| 78 | * regulation of neurotransmitter levels (GO:0001505) | 3.19561474 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.17775411 |
| 80 | dendrite morphogenesis (GO:0048813) | 3.16498225 |
| 81 | retinal rod cell development (GO:0046548) | 3.16497874 |
| 82 | membrane depolarization (GO:0051899) | 3.16324251 |
| 83 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.14724004 |
| 84 | regulation of neurotransmitter transport (GO:0051588) | 3.13761916 |
| 85 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.11640403 |
| 86 | striatum development (GO:0021756) | 3.11240228 |
| 87 | central nervous system neuron axonogenesis (GO:0021955) | 3.10904128 |
| 88 | mating behavior (GO:0007617) | 3.07594473 |
| 89 | neutrophil mediated immunity (GO:0002446) | 3.06713146 |
| 90 | establishment of mitochondrion localization (GO:0051654) | 3.06575337 |
| 91 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.04769537 |
| 92 | cell communication by electrical coupling (GO:0010644) | 3.04236210 |
| 93 | long term synaptic depression (GO:0060292) | 3.01567566 |
| 94 | layer formation in cerebral cortex (GO:0021819) | 3.01225894 |
| 95 | synaptic transmission (GO:0007268) | 2.99427694 |
| 96 | negative regulation of dendrite development (GO:2000171) | 2.97535164 |
| 97 | transmission of nerve impulse (GO:0019226) | 2.97217276 |
| 98 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.97112461 |
| 99 | positive regulation of synapse assembly (GO:0051965) | 2.97057318 |
| 100 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.96174679 |
| 101 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.96174679 |
| 102 | potassium ion homeostasis (GO:0055075) | 2.95509080 |
| 103 | relaxation of smooth muscle (GO:0044557) | 2.94233650 |
| 104 | regulation of vesicle fusion (GO:0031338) | 2.93643846 |
| 105 | cellular sodium ion homeostasis (GO:0006883) | 2.93618702 |
| 106 | myeloid leukocyte mediated immunity (GO:0002444) | 2.93584589 |
| 107 | behavioral fear response (GO:0001662) | 2.91786384 |
| 108 | behavioral defense response (GO:0002209) | 2.91786384 |
| 109 | auditory behavior (GO:0031223) | 2.91034407 |
| 110 | regulation of synaptic plasticity (GO:0048167) | 2.90713976 |
| 111 | regulation of dendritic spine development (GO:0060998) | 2.89970601 |
| 112 | positive regulation of neurotransmitter transport (GO:0051590) | 2.86670065 |
| 113 | fear response (GO:0042596) | 2.86654937 |
| 114 | dendritic spine morphogenesis (GO:0060997) | 2.84851206 |
| 115 | * synaptic vesicle transport (GO:0048489) | 2.84830881 |
| 116 | * establishment of synaptic vesicle localization (GO:0097480) | 2.84830881 |
| 117 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.84666519 |
| 118 | negative regulation of B cell mediated immunity (GO:0002713) | 2.84551380 |
| 119 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.84551380 |
| 120 | learning (GO:0007612) | 2.84371527 |
| 121 | nerve growth factor signaling pathway (GO:0038180) | 2.83779392 |
| 122 | olfactory bulb development (GO:0021772) | 2.81869365 |
| 123 | mechanosensory behavior (GO:0007638) | 2.81160359 |
| 124 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.80410756 |
| 125 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.80410756 |
| 126 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.80410756 |
| 127 | axonal fasciculation (GO:0007413) | 2.79150605 |
| 128 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.78886548 |
| 129 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.77702793 |
| 130 | amino acid import (GO:0043090) | 2.75844415 |
| 131 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.72612865 |
| 132 | neurofilament cytoskeleton organization (GO:0060052) | 2.67965742 |
| 133 | regulation of dendrite morphogenesis (GO:0048814) | 2.67931174 |
| 134 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65459495 |
| 135 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65459495 |
| 136 | modulation by symbiont of host immune response (GO:0052553) | 2.65459495 |
| 137 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65459495 |
| 138 | modulation by symbiont of host defense response (GO:0052031) | 2.65459495 |
| 139 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65459495 |
| 140 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.64434027 |
| 141 | response to auditory stimulus (GO:0010996) | 2.62788638 |
| 142 | neural tube formation (GO:0001841) | 2.61778072 |
| 143 | retinal ganglion cell axon guidance (GO:0031290) | 2.58904244 |
| 144 | synapse organization (GO:0050808) | 2.58564548 |
| 145 | proline transport (GO:0015824) | 2.58527943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.69211844 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.12366395 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90908926 |
| 4 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.89790962 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.88537840 |
| 6 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.77218401 |
| 7 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.76763699 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.64217669 |
| 9 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.41983578 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40695211 |
| 11 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.38216325 |
| 12 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.37524789 |
| 13 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.37524789 |
| 14 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.37194630 |
| 15 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.34324795 |
| 16 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.30477507 |
| 17 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.29258845 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.23204894 |
| 19 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.18774215 |
| 20 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.16702286 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.15250462 |
| 22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.14875775 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13779084 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12298343 |
| 25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.06467526 |
| 26 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.05988617 |
| 27 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02932389 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.01283593 |
| 29 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99878177 |
| 30 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.88514105 |
| 31 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.87717021 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87302513 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.86925398 |
| 34 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.86736169 |
| 35 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.85638974 |
| 36 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84247080 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.82076499 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.72631102 |
| 39 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.72200806 |
| 40 | P300_19829295_ChIP-Seq_ESCs_Human | 1.72121663 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.69149452 |
| 42 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.67529219 |
| 43 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.62725052 |
| 44 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53165734 |
| 45 | VDR_22108803_ChIP-Seq_LS180_Human | 1.46288578 |
| 46 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.45424635 |
| 47 | AR_25329375_ChIP-Seq_VCAP_Human | 1.42207316 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.39770206 |
| 49 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39698838 |
| 50 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38840891 |
| 51 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.37736591 |
| 52 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.37026093 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.33981130 |
| 54 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33367130 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.32465147 |
| 56 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30246994 |
| 57 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.28633549 |
| 58 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.28297560 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26372438 |
| 60 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26147095 |
| 61 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.25496153 |
| 62 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24163177 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23702189 |
| 64 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.23224341 |
| 65 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22579042 |
| 66 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.22494674 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21316989 |
| 68 | EWS_26573619_Chip-Seq_HEK293_Human | 1.20439235 |
| 69 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.19405238 |
| 70 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19114017 |
| 71 | TCF4_23295773_ChIP-Seq_U87_Human | 1.18226292 |
| 72 | TP53_16413492_ChIP-PET_HCT116_Human | 1.17844210 |
| 73 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17302658 |
| 74 | * AR_19668381_ChIP-Seq_PC3_Human | 1.16868997 |
| 75 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16034090 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15908465 |
| 77 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.14308432 |
| 78 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13987995 |
| 79 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.13507652 |
| 80 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.12079532 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11829233 |
| 82 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.10132632 |
| 83 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10027024 |
| 84 | * TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.09720326 |
| 85 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.09494873 |
| 86 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.09279139 |
| 87 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08553447 |
| 88 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.08142345 |
| 89 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08109596 |
| 90 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.08071436 |
| 91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08020518 |
| 92 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.08020518 |
| 93 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07814559 |
| 94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.04446412 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.04170210 |
| 96 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03779953 |
| 97 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.03675184 |
| 98 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02809405 |
| 99 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.01851960 |
| 100 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00986404 |
| 101 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00792451 |
| 102 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.00662930 |
| 103 | KDM2B_26808549_Chip-Seq_REH_Human | 0.99195221 |
| 104 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.99170151 |
| 105 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.98810957 |
| 106 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.98472408 |
| 107 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.98472408 |
| 108 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.98285280 |
| 109 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.95930677 |
| 110 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95402688 |
| 111 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.95204676 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.94671721 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.94106485 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.93985799 |
| 115 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.93562943 |
| 116 | * FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.93243185 |
| 117 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.93007066 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 0.92295473 |
| 119 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91508182 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.91250361 |
| 121 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.91196364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.74725137 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 4.63298210 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.65890044 |
| 4 | MP0009046_muscle_twitch | 3.45002519 |
| 5 | MP0000569_abnormal_digit_pigmentation | 3.24160332 |
| 6 | MP0009745_abnormal_behavioral_response | 3.16852796 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.14084161 |
| 8 | MP0004270_analgesia | 3.05351970 |
| 9 | MP0002064_seizures | 3.01496463 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.96648279 |
| 11 | MP0005551_abnormal_eye_electrophysiolog | 2.80691597 |
| 12 | MP0002272_abnormal_nervous_system | 2.70707045 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.66934510 |
| 14 | MP0002736_abnormal_nociception_after | 2.56756898 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.54704567 |
| 16 | MP0001486_abnormal_startle_reflex | 2.53991191 |
| 17 | MP0001984_abnormal_olfaction | 2.50395781 |
| 18 | MP0003121_genomic_imprinting | 2.41164722 |
| 19 | MP0005423_abnormal_somatic_nervous | 2.39110846 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.32720858 |
| 21 | MP0002067_abnormal_sensory_capabilities | 2.29051480 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.16504942 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.12846471 |
| 24 | MP0006276_abnormal_autonomic_nervous | 2.10946880 |
| 25 | MP0003890_abnormal_embryonic-extraembry | 2.02154669 |
| 26 | MP0002184_abnormal_innervation | 2.01245614 |
| 27 | MP0001502_abnormal_circadian_rhythm | 1.91013269 |
| 28 | MP0002822_catalepsy | 1.85001994 |
| 29 | MP0008569_lethality_at_weaning | 1.83776789 |
| 30 | MP0005386_behavior/neurological_phenoty | 1.73989164 |
| 31 | MP0004924_abnormal_behavior | 1.73989164 |
| 32 | MP0003724_increased_susceptibility_to | 1.72557199 |
| 33 | MP0002090_abnormal_vision | 1.72026567 |
| 34 | MP0006072_abnormal_retinal_apoptosis | 1.70760581 |
| 35 | MP0001970_abnormal_pain_threshold | 1.69044495 |
| 36 | MP0003879_abnormal_hair_cell | 1.67574693 |
| 37 | MP0005646_abnormal_pituitary_gland | 1.67451320 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.67295375 |
| 39 | MP0001188_hyperpigmentation | 1.66316957 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.65888605 |
| 41 | MP0003329_amyloid_beta_deposits | 1.59257265 |
| 42 | MP0000778_abnormal_nervous_system | 1.57390283 |
| 43 | MP0004145_abnormal_muscle_electrophysio | 1.55104720 |
| 44 | MP0001529_abnormal_vocalization | 1.53387983 |
| 45 | MP0003690_abnormal_glial_cell | 1.46344168 |
| 46 | MP0004142_abnormal_muscle_tone | 1.45082529 |
| 47 | MP0004811_abnormal_neuron_physiology | 1.38447588 |
| 48 | MP0000955_abnormal_spinal_cord | 1.38229703 |
| 49 | MP0002882_abnormal_neuron_morphology | 1.37594077 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.37349334 |
| 51 | MP0002928_abnormal_bile_duct | 1.35774908 |
| 52 | MP0005253_abnormal_eye_physiology | 1.35319520 |
| 53 | MP0002066_abnormal_motor_capabilities/c | 1.32330293 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.30391320 |
| 55 | MP0002229_neurodegeneration | 1.27108098 |
| 56 | MP0005187_abnormal_penis_morphology | 1.23418085 |
| 57 | MP0004742_abnormal_vestibular_system | 1.21848256 |
| 58 | MP0003633_abnormal_nervous_system | 1.16996721 |
| 59 | MP0008872_abnormal_physiological_respon | 1.16290921 |
| 60 | MP0008877_abnormal_DNA_methylation | 1.15930873 |
| 61 | MP0003221_abnormal_cardiomyocyte_apopto | 1.13694724 |
| 62 | MP0008875_abnormal_xenobiotic_pharmacok | 1.11343507 |
| 63 | MP0004885_abnormal_endolymph | 1.11308837 |
| 64 | MP0003122_maternal_imprinting | 1.11034656 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.10586111 |
| 66 | MP0004233_abnormal_muscle_weight | 1.08331615 |
| 67 | MP0001905_abnormal_dopamine_level | 1.05485094 |
| 68 | MP0005645_abnormal_hypothalamus_physiol | 1.04732752 |
| 69 | MP0002752_abnormal_somatic_nervous | 1.04485714 |
| 70 | MP0004215_abnormal_myocardial_fiber | 1.04212783 |
| 71 | MP0004858_abnormal_nervous_system | 1.03175975 |
| 72 | MP0003861_abnormal_nervous_system | 1.01368588 |
| 73 | MP0003631_nervous_system_phenotype | 1.00671330 |
| 74 | MP0002876_abnormal_thyroid_physiology | 1.00114487 |
| 75 | MP0003787_abnormal_imprinting | 0.98580252 |
| 76 | MP0002152_abnormal_brain_morphology | 0.98481380 |
| 77 | MP0005195_abnormal_posterior_eye | 0.95954635 |
| 78 | MP0005409_darkened_coat_color | 0.95831212 |
| 79 | MP0005535_abnormal_body_temperature | 0.95691771 |
| 80 | MP0005360_urolithiasis | 0.95429556 |
| 81 | MP0005365_abnormal_bile_salt | 0.95182849 |
| 82 | MP0008260_abnormal_autophagy | 0.94824888 |
| 83 | MP0004085_abnormal_heartbeat | 0.94587681 |
| 84 | MP0010386_abnormal_urinary_bladder | 0.94077028 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.93983143 |
| 86 | MP0006292_abnormal_olfactory_placode | 0.92198520 |
| 87 | MP0004130_abnormal_muscle_cell | 0.91830536 |
| 88 | MP0001963_abnormal_hearing_physiology | 0.90559403 |
| 89 | MP0000631_abnormal_neuroendocrine_gland | 0.88434683 |
| 90 | MP0002751_abnormal_autonomic_nervous | 0.87601821 |
| 91 | MP0003172_abnormal_lysosome_physiology | 0.86639516 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.86307086 |
| 93 | MP0000751_myopathy | 0.85334420 |
| 94 | MP0005394_taste/olfaction_phenotype | 0.83561097 |
| 95 | MP0005499_abnormal_olfactory_system | 0.83561097 |
| 96 | MP0003938_abnormal_ear_development | 0.83262844 |
| 97 | MP0005084_abnormal_gallbladder_morpholo | 0.82690232 |
| 98 | MP0008874_decreased_physiological_sensi | 0.81433956 |
| 99 | MP0002653_abnormal_ependyma_morphology | 0.80922561 |
| 100 | MP0002139_abnormal_hepatobiliary_system | 0.80148476 |
| 101 | MP0005410_abnormal_fertilization | 0.79886932 |
| 102 | MP0004883_abnormal_blood_vessel | 0.76757683 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.75954139 |
| 104 | MP0003183_abnormal_peptide_metabolism | 0.74358859 |
| 105 | MP0002332_abnormal_exercise_endurance | 0.74000448 |
| 106 | MP0005085_abnormal_gallbladder_physiolo | 0.73793139 |
| 107 | MP0003632_abnormal_nervous_system | 0.73582499 |
| 108 | MP0000604_amyloidosis | 0.73268295 |
| 109 | MP0000920_abnormal_myelination | 0.70822732 |
| 110 | MP0002009_preneoplasia | 0.70784911 |
| 111 | MP0003123_paternal_imprinting | 0.69933923 |
| 112 | MP0000534_abnormal_ureter_morphology | 0.69451392 |
| 113 | MP0003252_abnormal_bile_duct | 0.69267229 |
| 114 | MP0003011_delayed_dark_adaptation | 0.69044550 |
| 115 | MP0003942_abnormal_urinary_system | 0.68973939 |
| 116 | MP0010329_abnormal_lipoprotein_level | 0.68837967 |
| 117 | MP0004036_abnormal_muscle_relaxation | 0.68670967 |
| 118 | MP0006035_abnormal_mitochondrial_morpho | 0.68585843 |
| 119 | MP0001177_atelectasis | 0.68427382 |
| 120 | MP0003303_peritoneal_inflammation | 0.68262442 |
| 121 | * MP0002081_perinatal_lethality | 0.64925824 |
| 122 | MP0004043_abnormal_pH_regulation | 0.64694332 |
| 123 | MP0003137_abnormal_impulse_conducting | 0.64575440 |
| 124 | MP0004133_heterotaxia | 0.64108790 |
| 125 | MP0003119_abnormal_digestive_system | 0.63685746 |
| 126 | MP0005248_abnormal_Harderian_gland | 0.62828307 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.62582973 |
| 128 | MP0003634_abnormal_glial_cell | 0.61977104 |
| 129 | MP0000026_abnormal_inner_ear | 0.60877317 |
| 130 | MP0000013_abnormal_adipose_tissue | 0.60813857 |
| 131 | MP0005174_abnormal_tail_pigmentation | 0.60648389 |
| 132 | MP0004484_altered_response_of | 0.59528382 |
| 133 | MP0001324_abnormal_eye_pigmentation | 0.58060541 |
| 134 | * MP0001943_abnormal_respiration | 0.57221976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.74211482 |
| 2 | Congenital stationary night blindness (HP:0007642) | 6.14934441 |
| 3 | Epileptic encephalopathy (HP:0200134) | 5.76663138 |
| 4 | Febrile seizures (HP:0002373) | 5.47724831 |
| 5 | Atonic seizures (HP:0010819) | 5.07822992 |
| 6 | Focal seizures (HP:0007359) | 5.07085804 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 5.04782441 |
| 8 | Absence seizures (HP:0002121) | 4.86217159 |
| 9 | Visual hallucinations (HP:0002367) | 4.72474486 |
| 10 | Myokymia (HP:0002411) | 4.66086031 |
| 11 | Hyperventilation (HP:0002883) | 4.55117717 |
| 12 | Dialeptic seizures (HP:0011146) | 4.30277385 |
| 13 | Action tremor (HP:0002345) | 3.75512574 |
| 14 | Gaze-evoked nystagmus (HP:0000640) | 3.74046411 |
| 15 | Generalized tonic-clonic seizures (HP:0002069) | 3.71604086 |
| 16 | Papillary thyroid carcinoma (HP:0002895) | 3.49522888 |
| 17 | Broad-based gait (HP:0002136) | 3.47337606 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.44356436 |
| 19 | Abnormality of macular pigmentation (HP:0008002) | 3.41650167 |
| 20 | Central scotoma (HP:0000603) | 3.30285651 |
| 21 | Scanning speech (HP:0002168) | 3.27998098 |
| 22 | Truncal ataxia (HP:0002078) | 3.19513057 |
| 23 | Hemiparesis (HP:0001269) | 3.07503307 |
| 24 | Hepatoblastoma (HP:0002884) | 3.06611620 |
| 25 | Hypochromic microcytic anemia (HP:0004840) | 3.01374548 |
| 26 | Decreased central vision (HP:0007663) | 2.94625166 |
| 27 | Abnormality of the lower motor neuron (HP:0002366) | 2.93997355 |
| 28 | Dysmetric saccades (HP:0000641) | 2.92612544 |
| 29 | Genetic anticipation (HP:0003743) | 2.92049089 |
| 30 | Status epilepticus (HP:0002133) | 2.89309486 |
| 31 | Epileptiform EEG discharges (HP:0011182) | 2.88850101 |
| 32 | Drooling (HP:0002307) | 2.84047870 |
| 33 | Excessive salivation (HP:0003781) | 2.84047870 |
| 34 | Poor eye contact (HP:0000817) | 2.82101804 |
| 35 | Impaired smooth pursuit (HP:0007772) | 2.79080206 |
| 36 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.78794273 |
| 37 | EEG with generalized epileptiform discharges (HP:0011198) | 2.74767140 |
| 38 | Amyotrophic lateral sclerosis (HP:0007354) | 2.72827983 |
| 39 | Dysmetria (HP:0001310) | 2.66393291 |
| 40 | Impaired social interactions (HP:0000735) | 2.60691906 |
| 41 | Abnormal social behavior (HP:0012433) | 2.60691906 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.60657852 |
| 43 | Anxiety (HP:0000739) | 2.59417160 |
| 44 | Depression (HP:0000716) | 2.58633111 |
| 45 | Amblyopia (HP:0000646) | 2.58101605 |
| 46 | Cortical dysplasia (HP:0002539) | 2.53371732 |
| 47 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.51854584 |
| 48 | Peritonitis (HP:0002586) | 2.50496197 |
| 49 | Aqueductal stenosis (HP:0002410) | 2.50417218 |
| 50 | Cholecystitis (HP:0001082) | 2.49778926 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 2.49778926 |
| 52 | Gait imbalance (HP:0002141) | 2.47772430 |
| 53 | Hypsarrhythmia (HP:0002521) | 2.41451302 |
| 54 | Polyphagia (HP:0002591) | 2.41414902 |
| 55 | Lower limb muscle weakness (HP:0007340) | 2.39768843 |
| 56 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.38570343 |
| 57 | Thyroid carcinoma (HP:0002890) | 2.36866954 |
| 58 | Absent speech (HP:0001344) | 2.34760124 |
| 59 | Severe visual impairment (HP:0001141) | 2.33940578 |
| 60 | Vitreoretinal degeneration (HP:0000655) | 2.33784802 |
| 61 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.33614926 |
| 62 | Pheochromocytoma (HP:0002666) | 2.32058432 |
| 63 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.31252689 |
| 64 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.31252689 |
| 65 | Mutism (HP:0002300) | 2.26422014 |
| 66 | Gastrointestinal infarctions (HP:0005244) | 2.25961470 |
| 67 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.25495978 |
| 68 | Optic neuritis (HP:0100653) | 2.23029175 |
| 69 | Retrobulbar optic neuritis (HP:0100654) | 2.23029175 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.22094476 |
| 71 | Congenital primary aphakia (HP:0007707) | 2.22072364 |
| 72 | Choroideremia (HP:0001139) | 2.21966169 |
| 73 | Inability to walk (HP:0002540) | 2.21699895 |
| 74 | Progressive inability to walk (HP:0002505) | 2.19321738 |
| 75 | Scotoma (HP:0000575) | 2.19126099 |
| 76 | Protruding tongue (HP:0010808) | 2.18500918 |
| 77 | Supranuclear gaze palsy (HP:0000605) | 2.16134609 |
| 78 | Spastic gait (HP:0002064) | 2.11282433 |
| 79 | Lissencephaly (HP:0001339) | 2.11068582 |
| 80 | Lower limb asymmetry (HP:0100559) | 2.10618993 |
| 81 | Generalized hypotonia (HP:0001290) | 2.10245791 |
| 82 | Papilledema (HP:0001085) | 2.10029281 |
| 83 | Hemiplegia (HP:0002301) | 2.09848571 |
| 84 | Postural instability (HP:0002172) | 2.09640964 |
| 85 | Deep venous thrombosis (HP:0002625) | 2.06383513 |
| 86 | Intention tremor (HP:0002080) | 2.04750321 |
| 87 | Neuroendocrine neoplasm (HP:0100634) | 2.04601779 |
| 88 | Megalencephaly (HP:0001355) | 2.04499441 |
| 89 | Generalized myoclonic seizures (HP:0002123) | 2.03172821 |
| 90 | Fetal akinesia sequence (HP:0001989) | 2.02945895 |
| 91 | Diplopia (HP:0000651) | 2.02561677 |
| 92 | Abnormality of binocular vision (HP:0011514) | 2.02561677 |
| 93 | Nephrogenic diabetes insipidus (HP:0009806) | 2.01899765 |
| 94 | Shawl scrotum (HP:0000049) | 2.01559255 |
| 95 | Inappropriate behavior (HP:0000719) | 1.99893248 |
| 96 | Blue irides (HP:0000635) | 1.99775501 |
| 97 | Failure to thrive in infancy (HP:0001531) | 1.98624703 |
| 98 | Intellectual disability, moderate (HP:0002342) | 1.96693469 |
| 99 | Torticollis (HP:0000473) | 1.95729752 |
| 100 | Agitation (HP:0000713) | 1.95210577 |
| 101 | Impaired vibratory sensation (HP:0002495) | 1.94086027 |
| 102 | Abnormality of the corticospinal tract (HP:0002492) | 1.93983528 |
| 103 | Gait ataxia (HP:0002066) | 1.93907103 |
| 104 | Limb ataxia (HP:0002070) | 1.93608065 |
| 105 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.93472302 |
| 106 | Absent/shortened dynein arms (HP:0200106) | 1.93472302 |
| 107 | Orchitis (HP:0100796) | 1.92331478 |
| 108 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91126562 |
| 109 | Ankle clonus (HP:0011448) | 1.90509249 |
| 110 | Bradykinesia (HP:0002067) | 1.89293754 |
| 111 | Heterochromia iridis (HP:0001100) | 1.89171215 |
| 112 | Specific learning disability (HP:0001328) | 1.88951360 |
| 113 | Limb dystonia (HP:0002451) | 1.88849873 |
| 114 | Genital tract atresia (HP:0001827) | 1.88652284 |
| 115 | Abnormality of saccadic eye movements (HP:0000570) | 1.87638408 |
| 116 | Vaginal atresia (HP:0000148) | 1.85263047 |
| 117 | Stereotypic behavior (HP:0000733) | 1.84969984 |
| 118 | Esotropia (HP:0000565) | 1.84634896 |
| 119 | Abnormality of the labia minora (HP:0012880) | 1.83110822 |
| 120 | Myelomeningocele (HP:0002475) | 1.82662894 |
| 121 | Fair hair (HP:0002286) | 1.81862733 |
| 122 | Focal dystonia (HP:0004373) | 1.80755277 |
| 123 | Intellectual disability, severe (HP:0010864) | 1.80237604 |
| 124 | Pachygyria (HP:0001302) | 1.79707362 |
| 125 | Abnormal hair whorl (HP:0010721) | 1.79196206 |
| 126 | Medulloblastoma (HP:0002885) | 1.78778969 |
| 127 | Narrow nasal bridge (HP:0000446) | 1.77237909 |
| 128 | Cerebral inclusion bodies (HP:0100314) | 1.77227674 |
| 129 | Hypochromic anemia (HP:0001931) | 1.76893121 |
| 130 | Clonus (HP:0002169) | 1.76478298 |
| 131 | Recurrent bacterial skin infections (HP:0005406) | 1.76415336 |
| 132 | Poor coordination (HP:0002370) | 1.75972726 |
| 133 | Insidious onset (HP:0003587) | 1.74774810 |
| 134 | Termporal pattern (HP:0011008) | 1.74774810 |
| 135 | Incomplete penetrance (HP:0003829) | 1.73771494 |
| 136 | Abnormality of salivation (HP:0100755) | 1.72219680 |
| 137 | Dyskinesia (HP:0100660) | 1.71618637 |
| 138 | Gingival bleeding (HP:0000225) | 1.71587021 |
| 139 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.71426202 |
| 140 | Recurrent abscess formation (HP:0002722) | 1.71382531 |
| 141 | Septo-optic dysplasia (HP:0100842) | 1.69829813 |
| 142 | Hypoplasia of the brainstem (HP:0002365) | 1.69692267 |
| 143 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.69692267 |
| 144 | Urinary urgency (HP:0000012) | 1.69550420 |
| 145 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.69247450 |
| 146 | Exotropia (HP:0000577) | 1.68809727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.37849065 |
| 2 | NTRK3 | 3.72373613 |
| 3 | MAP3K4 | 3.48007669 |
| 4 | EPHA4 | 3.24891654 |
| 5 | MAP2K7 | 3.00683444 |
| 6 | MAP3K9 | 2.87854504 |
| 7 | MARK1 | 2.69199212 |
| 8 | DAPK2 | 2.67854448 |
| 9 | MINK1 | 2.59364614 |
| 10 | MAP2K4 | 2.29142508 |
| 11 | PAK6 | 1.96230867 |
| 12 | MAP3K12 | 1.93580390 |
| 13 | PRPF4B | 1.89332664 |
| 14 | PNCK | 1.86622762 |
| 15 | NTRK2 | 1.79668813 |
| 16 | PLK2 | 1.77940713 |
| 17 | CAMKK2 | 1.71647622 |
| 18 | DYRK2 | 1.66696232 |
| 19 | YES1 | 1.51748076 |
| 20 | DAPK1 | 1.51443153 |
| 21 | CDK19 | 1.51134356 |
| 22 | GRK5 | 1.50883627 |
| 23 | KSR1 | 1.50201720 |
| 24 | RIPK4 | 1.49543407 |
| 25 | AKT3 | 1.44813583 |
| 26 | PRKCG | 1.42181290 |
| 27 | CAMKK1 | 1.40194915 |
| 28 | DYRK3 | 1.36721352 |
| 29 | FGFR2 | 1.34178806 |
| 30 | MAPK13 | 1.33793202 |
| 31 | SIK2 | 1.33561882 |
| 32 | DYRK1B | 1.33426987 |
| 33 | TNIK | 1.32649519 |
| 34 | CDK5 | 1.29438571 |
| 35 | EPHA3 | 1.27250463 |
| 36 | SGK494 | 1.24502898 |
| 37 | SGK223 | 1.24502898 |
| 38 | STK38 | 1.24379418 |
| 39 | SGK2 | 1.19535496 |
| 40 | CAMK2A | 1.18826098 |
| 41 | CCNB1 | 1.18664497 |
| 42 | SIK3 | 1.13864486 |
| 43 | KSR2 | 1.09351435 |
| 44 | DYRK1A | 1.07399655 |
| 45 | OXSR1 | 1.00194737 |
| 46 | PTK2B | 1.00148732 |
| 47 | NTRK1 | 0.99036576 |
| 48 | TRIM28 | 0.98445684 |
| 49 | PHKG2 | 0.97962015 |
| 50 | PHKG1 | 0.97962015 |
| 51 | ARAF | 0.93649335 |
| 52 | FES | 0.92440679 |
| 53 | CDK18 | 0.89851531 |
| 54 | WNK3 | 0.88306640 |
| 55 | CAMK2B | 0.88234511 |
| 56 | STK38L | 0.87489068 |
| 57 | INSRR | 0.87417283 |
| 58 | NME1 | 0.87256339 |
| 59 | CAMK1 | 0.86361790 |
| 60 | CDK15 | 0.84966826 |
| 61 | MAP3K13 | 0.84052773 |
| 62 | CDK14 | 0.83444326 |
| 63 | EPHB1 | 0.80366222 |
| 64 | IRAK2 | 0.79646316 |
| 65 | JAK2 | 0.79256796 |
| 66 | TNK2 | 0.77790104 |
| 67 | BLK | 0.77606295 |
| 68 | CAMK1G | 0.76877646 |
| 69 | BMPR2 | 0.76835829 |
| 70 | SGK3 | 0.76734442 |
| 71 | TYRO3 | 0.76246314 |
| 72 | CAMK2D | 0.75590605 |
| 73 | BRD4 | 0.74752333 |
| 74 | MAP3K5 | 0.74722550 |
| 75 | TAOK2 | 0.74144468 |
| 76 | CDK11A | 0.72554389 |
| 77 | UHMK1 | 0.72358239 |
| 78 | PDK3 | 0.68975524 |
| 79 | PDK4 | 0.68975524 |
| 80 | PINK1 | 0.68157239 |
| 81 | WNK1 | 0.66792207 |
| 82 | PRKCE | 0.66502256 |
| 83 | STK11 | 0.66480204 |
| 84 | SGK1 | 0.66403737 |
| 85 | CAMK1D | 0.65340102 |
| 86 | PIK3CA | 0.64352497 |
| 87 | CAMK2G | 0.63894704 |
| 88 | RPS6KB1 | 0.63226711 |
| 89 | CAMK4 | 0.62722939 |
| 90 | MAP3K2 | 0.62254103 |
| 91 | MARK2 | 0.61135255 |
| 92 | IRAK4 | 0.60550255 |
| 93 | PRKCZ | 0.59951829 |
| 94 | BCR | 0.57858564 |
| 95 | ADRBK2 | 0.57124533 |
| 96 | PKN2 | 0.56956740 |
| 97 | PRKG1 | 0.55365698 |
| 98 | CDK3 | 0.55061550 |
| 99 | CSNK1A1L | 0.55026945 |
| 100 | FER | 0.54894366 |
| 101 | FGFR3 | 0.54678556 |
| 102 | MAPK12 | 0.54085826 |
| 103 | PAK3 | 0.53604375 |
| 104 | RET | 0.51726505 |
| 105 | PRKACA | 0.50789688 |
| 106 | ROCK2 | 0.50148215 |
| 107 | TAOK1 | 0.49942765 |
| 108 | FRK | 0.49338639 |
| 109 | RIPK1 | 0.49325531 |
| 110 | RPS6KA3 | 0.49305408 |
| 111 | BRAF | 0.49226917 |
| 112 | GRK7 | 0.48266342 |
| 113 | FGR | 0.46926120 |
| 114 | ERBB3 | 0.46157098 |
| 115 | PRKCH | 0.45303981 |
| 116 | PDK1 | 0.44223209 |
| 117 | PRKCB | 0.43859603 |
| 118 | CSNK1G3 | 0.43469742 |
| 119 | ADRBK1 | 0.42815580 |
| 120 | MAP3K6 | 0.42734111 |
| 121 | CSNK1G2 | 0.42348340 |
| 122 | PKN1 | 0.42184927 |
| 123 | CSK | 0.42091370 |
| 124 | ALK | 0.41705548 |
| 125 | PRKCA | 0.41012685 |
| 126 | NEK1 | 0.40658449 |
| 127 | PRKACB | 0.39507107 |
| 128 | MAP2K3 | 0.39422431 |
| 129 | SYK | 0.37594567 |
| 130 | ERBB2 | 0.36423940 |
| 131 | FYN | 0.35988668 |
| 132 | RAF1 | 0.35952639 |
| 133 | MAP2K1 | 0.35702219 |
| 134 | MAPK10 | 0.32665497 |
| 135 | IRAK1 | 0.31347806 |
| 136 | STK24 | 0.30635578 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.74748880 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.51571303 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 3.02280349 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 3.00929333 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.65128261 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.55872473 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50741156 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.23969398 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.23445276 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.11166784 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.08463004 |
| 12 | Taste transduction_Homo sapiens_hsa04742 | 1.96805835 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.88674110 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.87042714 |
| 15 | Insulin secretion_Homo sapiens_hsa04911 | 1.86133431 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.84642651 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.80146199 |
| 18 | Renin secretion_Homo sapiens_hsa04924 | 1.78870912 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.76961764 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.76031242 |
| 21 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.73233460 |
| 22 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.69974613 |
| 23 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.59063379 |
| 24 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.59040234 |
| 25 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.52460898 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52021965 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.47052313 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.46975852 |
| 29 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.38265326 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.37013702 |
| 31 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.36881092 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.36021695 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.29481921 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.23165624 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.22238719 |
| 36 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18620173 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18198931 |
| 38 | Endometrial cancer_Homo sapiens_hsa05213 | 1.15725959 |
| 39 | Gap junction_Homo sapiens_hsa04540 | 1.12596933 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11769227 |
| 41 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.05575268 |
| 42 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.05395731 |
| 43 | Circadian rhythm_Homo sapiens_hsa04710 | 1.03791537 |
| 44 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.02663704 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02303089 |
| 46 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.02250002 |
| 47 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.97728944 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.97346856 |
| 49 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97123709 |
| 50 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.96499497 |
| 51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.96441986 |
| 52 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95856288 |
| 53 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95119839 |
| 54 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.89440123 |
| 55 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.88821145 |
| 56 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88641237 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.87353523 |
| 58 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.87131224 |
| 59 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.87014734 |
| 60 | Bile secretion_Homo sapiens_hsa04976 | 0.86340208 |
| 61 | Colorectal cancer_Homo sapiens_hsa05210 | 0.86171233 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.85828876 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.85395366 |
| 64 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84144046 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79991002 |
| 66 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.79215440 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.77644968 |
| 68 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.77052375 |
| 69 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74198763 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.73898673 |
| 71 | Axon guidance_Homo sapiens_hsa04360 | 0.71771611 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.71220779 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.70193298 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.69880675 |
| 75 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.69465446 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.69416431 |
| 77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.67185314 |
| 78 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.65934171 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65160942 |
| 80 | Tuberculosis_Homo sapiens_hsa05152 | 0.64709667 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.62237842 |
| 82 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61912247 |
| 83 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.61307670 |
| 84 | Melanogenesis_Homo sapiens_hsa04916 | 0.59673887 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59609744 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58940239 |
| 87 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58792361 |
| 88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.58346568 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58333707 |
| 90 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58293293 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.57275118 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.57087260 |
| 93 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.56397652 |
| 94 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.56357119 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.56208389 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55994994 |
| 97 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51616898 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50820006 |
| 99 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.50528699 |
| 100 | Glioma_Homo sapiens_hsa05214 | 0.50344209 |
| 101 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48262647 |
| 102 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.48179413 |
| 103 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47633597 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47044233 |
| 105 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45595741 |
| 106 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45388332 |
| 107 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.44840120 |
| 108 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43287167 |
| 109 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41104966 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.40394643 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40370232 |
| 112 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39675814 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39183107 |
| 114 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.36392232 |
| 115 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34290658 |
| 116 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33960354 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.32539163 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31812418 |
| 119 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.29086417 |
| 120 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.28872011 |
| 121 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28180221 |
| 122 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27970882 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26750277 |
| 124 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.25772034 |
| 125 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.25169813 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.24237817 |
| 127 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.23439460 |
| 128 | Huntingtons disease_Homo sapiens_hsa05016 | 0.22560066 |
| 129 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.22440513 |
| 130 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.21595889 |
| 131 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.21375188 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.20672654 |
| 133 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20267528 |
| 134 | ABC transporters_Homo sapiens_hsa02010 | 0.19570487 |
| 135 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.19284440 |

